RecallDepth
Class II Completed

Duloxetine Delayed-Release Capsules, USP, 60mg, 90-count bottle, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-90

Company
Breckenridge Pharmaceutical, Inc
Recall Initiated
May 17, 2024
Posted
June 26, 2024
Recall Number
D-0562-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
165,678, 90-count bottles
Firm Location
Berlin, CT, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 230035C, Exp. date 11/30/2025; 230101C, Exp. date 12/31/2025

More recalls by Breckenridge Pharmaceutical, Inc

View all recalls by this company →

Other recent Class II Drug recalls